Nelson memo

The Nelson Memo: Igniting a Global Open Data Revolution

The landscape of scientific research is undergoing a seismic shift, driven by an urgent demand for transparency, reproducibility, and equitable access. At the epicenter of this transformation in the United States is the Nelson Memo, a policy directive rapidly accelerating the future of open science. With the National Institutes of Health (NIH)'s recent announcement (NOT-OD-25-101)…...
Read More

Top Stories

MAPS 2025

MAPS 2025 Decoded: The Medical Affairs Playbook

At the MAPS Americas 2025 conference in New Orleans, one of...
DIA MASC 2025

Medical Affairs 2.0: GenAI as the Catalyst for

Digital and AI were hot topics underpinning many of the...

The Paradigm Shift from Traditional Scientific

In the rapidly evolving biopharma landscape, the approach to...
World Patient Safety Day, Patient Involvement, Patient Engagement, Listening to Patients, Patient centricity

World Patient Safety Day 2023: Engaging Patients for Patient Safety

Join us on World Patient Safety Day 2023 as we emphasize the transformative power of...
HEOR Pharma Payers

Didactic to Dynamic: Innovative Approaches to Deeper Payer Engagements

HEOR is a fast-evolving field. Feedback from payers can influence research plans and help create...
Health Literacy

Health Literacy – Cactus Life Sciences Leads the Way

It’s our responsibility as an industry to emphasize the importance of health literacy and help...

Medical Information in the Digital Age – Quick and Efficient Meets Responsive and Responsible

Medical Information (MI teams across the pharmaceutical industry respond to product-related medical queries from HCPs...
Medication without Harm

World Patient Safety Day 2022 – Medication Without Harm

Medication use around the world has increased in the last few years; a 2019 CDC...
Image - What Makes Stakeholders Trust Pharma-Generated Scientific Content and How Can the Industry Do Better

What Makes Stakeholders Trust Pharma-Generated Scientific Content and How Can the Industry Do Better?

While diverse pharma stakeholders are now consuming scientific content digitally more than ever before, the...

Learn more ABOUT our company.